Trading status Status de
  • Prices realtime
    • Indizes
      • Germany 40
      • MID Germany 50
      • TEC Germany 30
      • USA 30
      • EUROPE 50
      • TEC USA 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 9767
  • 9768
  • 9769
  • …
  • ›
  • »

2026-03-24

Man Group PLC : Form 8.3 - Just Group Plc

2026-03-24

Opus Genetics Named to Fast Company′s Annual List of the World′s Most Innovative Companies of 2026

2026-03-24

OTC Markets Group Welcomes Brixton Metals Corp. to OTCQX

2026-03-24

Troilus Completes Basic Engineering and Advances Detailed Engineering as Project Execution Readiness Accelerates

2026-03-24

Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

2026-03-24

Spectral Medical and Vantive Announce Publication of Complete Results from Spectral′s Tigris Trial in the Lancet Respiratory Medicine

2026-03-24

PPHC Added to Russell 2000® and Russell 3000® Indexes

2026-03-24

Aben Gold Corp. Assesses Historical Tungsten Results from 2014 Re-Assay Program and Plans 2026 Exploration Program to Target Both Tungsten and Gold at the Justin Project

2026-03-24

Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

2026-03-24

Outlook Therapeutics Announces Pricing of $5.0 Million Public Offering

2026-03-24

NRx Pharmaceuticals (Nasdaq:NRXP) Reports Full-Year 2025 Results and Highlights Key Regulatory and Commercial Progress

2026-03-24

Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting

  • «
  • ‹
  • …
  • 9767
  • 9768
  • 9769
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies